Summary
The leading business intelligence provider GBI Research has released its latest research report. The report provides insights into the vaccines in the Travel Vaccines market including market forecasts up to 2019. It provides an in-depth analysis of the travel vaccines, as well as insights into the Travel Vaccines R&D pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global Travel Vaccines market. The report analyzes the market for Travel Vaccines in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. In addition, it provides overview of vaccines market in India, China and Australia including regulatory frameworks and profiles of the top companies, deals and pipeline analysis. The report discusses the global pipeline for Travel Vaccines across various stages of development.

Scope
- Annualized market data for the Travel Vaccines market from 2007 to 2012, forecast forward to 2019.
- Analysis of the Travel Vaccines market in the leading geographies of the world, which includes the US, the UK, Germany, France, Italy, Spain, and Japan.
- Market characterization of the Travel Vaccines market including market size, cost of vaccination.
- Key drivers and barriers that have a significant impact on the market.
- Coverage of pipeline molecules in various phases of vaccine development.
- Competitive benchmarking of leading companies. Key companies studied in this report are GlaxoSmithKline, Sanofi, Pfizer, Merck and Novartis.

Reasons to buy
- Align your product portfolio to the markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the potential region and Travel Vaccines market segments poised for strong growth.
- Create a more tailored country strategy through the understanding of key drivers and barriers of the global Travel Vaccines market.
- Develop key strategic initiatives by understanding the key focus areas and top selling products of leading companies.
To order this report:
Email: [email protected]
US: +1 866 325 7446
UK: +44 203 514 2363
India: +91 22 4098 7600
RELATED LINK:
http://www.researchonglobalmarkets.com/travel-vaccines-market-to-2019-hepatitis-a-japanese-encephalitis-and-meningococcal-vaccine-segments-to-drive-growth.html